A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to evaluate the effects of L-glutamine as a therapy for
Sickle Cell Anemia or Sickle ß0 Thalassemia as evaluated by the number of occurrences of
sickle cell crises.